<bill session="115" type="s" number="3680" updated="2019-07-19T21:27:28Z">
  <state datetime="2018-11-29">REFERRED</state>
  <status>
    <introduced datetime="2018-11-29"/>
  </status>
  <introduced datetime="2018-11-29"/>
  <titles>
    <title type="official" as="introduced">A bill to require the Secretary of Health and Human Services to establish reference prices for prescription drugs for purposes of Federal health programs.</title>
    <title type="short" as="introduced">Low Drug Prices Act</title>
    <title type="short" as="introduced">Low Drug Prices Act</title>
    <title type="display">Low Drug Prices Act</title>
  </titles>
  <sponsor bioguide_id="M001176"/>
  <cosponsors/>
  <actions>
    <action datetime="2018-11-29">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2018-11-29" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2018-11-29T05:00:00Z" status="Introduced in Senate">Low Drug Prices Act

This bill requires the Department of Health and Human Services to establish maximum prices for prescription drugs that are covered under specified federal programs (e.g., Medicare) based on drug prices in listed reference countries.</summary>
  <committee-reports/>
</bill>
